Clinical trial
PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
NCT00053885 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00053885 |
|---|---|
| Title | PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma |
| Official title | A Phase II Study of PTK787/ZK222584 (NSC#719335) in Patients With Unresectable Malignant Mesothelioma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Mesothelioma |
| Intervention type | Drug |
| Interventions | PTK787/ZK 222584 |
| Enrollment | 47 |
| Start date | Jul 1, 2003 |
| Primary completion | Jul 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Feb 6, 2003 |
| Last update posted | Jul 1, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: